(MedPage Today) — A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term follow-up results from the European Randomized Study of Screening for Prostate Cancer.
After a median…
Source link : https://www.medpagetoday.com/hematologyoncology/prostatecancer/118218
Author :
Publish date : 2025-10-29 21:00:00
Copyright for syndicated content belongs to the linked Source.
